Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1C1C1007122).
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29 https://doi.org/10.3322/caac.21254
- Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet 2015;385:2197-2208 https://doi.org/10.1016/S0140-6736(14)60493-1
- International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol 2003;121:749-757 https://doi.org/10.1046/j.1365-2141.2003.04355.x
- Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004;126:348-354 https://doi.org/10.1111/j.1365-2141.2004.05045.x
- Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 2007;356:2582-2590 https://doi.org/10.1056/NEJMoa070389
- Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA 2022;327:464-477 https://doi.org/10.1001/jama.2022.0003
- Terpos E, Zamagni E, Lentzsch S, Drake MT, Garcia-Sanz R, Abildgaard N, et al. Treatment of multiple myeloma-related bone disease: recommendations from the bone working group of the international myeloma working group. Lancet Oncol 2021;22:e119-e130 https://doi.org/10.1016/S1470-2045(20)30559-3
- Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538-e548 https://doi.org/10.1016/S1470-2045(14)70442-5
- Kastritis E, Moulopoulos LA, Terpos E, Koutoulidis V, Dimopoulos MA. The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma. Leukemia 2014;28:2402-2403 https://doi.org/10.1038/leu.2014.230
- Larsen JT, Kumar SK, Dispenzieri A, Kyle RA, Katzmann JA, Rajkumar SV. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma. Leukemia 2013;27:941-946 https://doi.org/10.1038/leu.2012.296
- Ghanem N, Lohrmann C, Engelhardt M, Pache G, Uhl M, Saueressig U, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006;16:1005-1014 https://doi.org/10.1007/s00330-005-0055-7
- Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol 1967;18:158-162 https://doi.org/10.1016/S0009-9260(67)80010-2
- Hillengass J, Fechtner K, Weber MA, Bauerle T, Ayyaz S, Heiss C, et al. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 2010;28:1606-1610 https://doi.org/10.1200/JCO.2009.25.5356
- Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M, et al. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients. Am J Hematol 2012;87:861-864 https://doi.org/10.1002/ajh.23258
- D'Anastasi M, Notohamiprodjo M, Schmidt GP, Durr HR, Reiser MF, Baur-Melnyk A. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI. AJR Am J Roentgenol 2014;203:854-862 https://doi.org/10.2214/AJR.13.10724
- Herget GW, Wasch R, Klein L, Schmal H, Terpos E, Engelhardt M. Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment. Haematologica 2020;105:859-861 https://doi.org/10.3324/haematol.2019.245423
- Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, et al. Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 1997;204:201-205 https://doi.org/10.1148/radiology.204.1.9205247
- Blackledge MD, Collins DJ, Tunariu N, Orton MR, Padhani AR, Leach MO, et al. Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study. PLoS One 2014;9:e91779
- Pawlyn C, Fowkes L, Otero S, Jones JR, Boyd KD, Davies FE, et al. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia 2016;30:1446-1448 https://doi.org/10.1038/leu.2015.338
- Winfield JM, Poillucci G, Blackledge MD, Collins DJ, Shah V, Tunariu N, et al. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. Eur Radiol 2018;28:1687-1691 https://doi.org/10.1007/s00330-017-5079-2
- Dong H, Huang W, Ji X, Huang L, Zou D, Hao M, et al. Prediction of early treatment response in multiple myeloma using MY-RADS total burden score, ADC, and fat fraction from whole-body MRI: impact of anemia on predictive performance. AJR Am J Roentgenol 2022;218:310-319 https://doi.org/10.2214/AJR.21.26534
- Jo A, Jung JY, Lee SY, Lee SE, Park H, Lee SE, et al. Prognosis prediction in initially diagnosed multiple myeloma patients using intravoxel incoherent motion-diffusion weighted imaging and multiecho dixon imaging. J Magn Reson Imaging 2021;53:491-501 https://doi.org/10.1002/jmri.27321
- Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology 2019;291:5-13 https://doi.org/10.1148/radiol.2019181949
- Barnes A, Alonzi R, Blackledge M, Charles-Edwards G, Collins DJ, Cook G, et al. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. Br J Radiol 2018;91:20170577
- Padhani AR, van Ree K, Collins DJ, D'Sa S, Makris A. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR Am J Roentgenol 2013;200:163-170 https://doi.org/10.2214/AJR.11.8185
- Perez-Lopez R, Nava Rodrigues D, Figueiredo I, Mateo J, Collins DJ, Koh DM, et al. Multiparametric magnetic resonance imaging of prostate cancer bone disease: correlation with bone biopsy histological and molecular features. Invest Radiol 2018;53:96-102 https://doi.org/10.1097/RLI.0000000000000415
- Lecouvet FE. Whole-body MR imaging: musculoskeletal applications. Radiology 2016;279:345-365 https://doi.org/10.1148/radiol.2016142084
- Koh DM, Blackledge M, Padhani AR, Takahara T, Kwee TC, Leach MO, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 2012;199:252-262 https://doi.org/10.2214/AJR.11.7866
- Anagnostopoulos A, Hamilos G, Zorzou MP, Grigoraki V, Anagnostou D, Dimopoulos MA. Discordant response or progression in patients with myeloma treated with thalidomide-based regimens. Leuk Lymphoma 2004;45:113-116 https://doi.org/10.1080/1042819031000151860
- Zamagni E, Tacchetti P, Cavo M. Imaging in multiple myeloma: how? when? Blood 2019;133:644-651 https://doi.org/10.1182/blood-2018-08-825356
- Lin C, Luciani A, Belhadj K, Deux JF, Kuhnowski F, Maatouk M, et al. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging. Radiology 2010;254:521-531 https://doi.org/10.1148/radiol.09090629
- Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 2019;20:e302-e312 https://doi.org/10.1016/S1470-2045(19)30309-2
- Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, et al. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response. Cancer Imaging 2020;20:14
- Derlin T, Peldschus K, Munster S, Bannas P, Herrmann J, Stubig T, et al. Comparative diagnostic performance of 18F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation. Eur Radiol 2013;23:570-578 https://doi.org/10.1007/s00330-012-2600-5
- Baik JS, Jung JY, Jee WH, Chun CW, Kim SK, Shin SH, et al. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI. J Magn Reson Imaging 2017;46:49-60 https://doi.org/10.1002/jmri.25536
- Sung MS, Lee GK, Kang HS, Kwon ST, Park JG, Suh JS, et al. Sacrococcygeal chordoma: MR imaging in 30 patients. Skeletal Radiol 2005;34:87-94 https://doi.org/10.1007/s00256-004-0840-4
- Moulopoulos LA, Varma DG, Dimopoulos MA, Leeds NE, Kim EE, Johnston DA, et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992;185:833-840 https://doi.org/10.1148/radiology.185.3.1438772
- Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 1996;167:1029-1036 https://doi.org/10.2214/ajr.167.4.8819407
- Lee SY, Kim HJ, Shin YR, Park HJ, Lee YG, Oh SJ. Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis. Eur Radiol 2017;27:2333-2347 https://doi.org/10.1007/s00330-016-4543-8
- Ricci C, Cova M, Kang YS, Yang A, Rahmouni A, Scott WW Jr, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990;177:83-88 https://doi.org/10.1148/radiology.177.1.2399343
- Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 2015;33:657-664 https://doi.org/10.1200/JCO.2014.57.9961
- Rahmouni A, Divine M, Mathieu D, Golli M, Haioun C, Dao T, et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 1993;160:1053-1057 https://doi.org/10.2214/ajr.160.5.8470575
- Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of response to treatment. Radiology 1994;193:441-446 https://doi.org/10.1148/radiology.193.2.7972760
- Drueke TB, Massy ZA. Beta2-microglobulin. Semin Dial 2009;22:378-380 https://doi.org/10.1111/j.1525-139X.2009.00584.x
- Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 2006;42:1539-1543 https://doi.org/10.1016/j.ejca.2005.11.037
- Baur A, Stabler A, Nagel D, Lamerz R, Bartl R, Hiller E, et al. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? Cancer 2002;95:1334-1345 https://doi.org/10.1002/cncr.10818
- Koutoulidis V, Fontara S, Terpos E, Zagouri F, Matsaridis D, Christoulas D, et al. Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology 2017;282:484-493 https://doi.org/10.1148/radiol.2016160363
- Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun 2017;8:268
- Blade J, Perales M, Rosinol L, Tuset M, Montoto S, Esteve J, et al. Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas. Br J Haematol 2001;113:422-424 https://doi.org/10.1046/j.1365-2141.2001.02765.x
- Rager O, Espinet C, Humm J, Weber W. Mixed response on FDG PET/CT: frequency and prognostic relevance in non-small cell lung cancer (NSCLC). J Nucl Med 2014;55(supplement 1):514
- Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, et al. Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Ann Oncol 2012;23:1687-1693 https://doi.org/10.1093/annonc/mdr554
- Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, et al. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 2008;112:196-207 https://doi.org/10.1182/blood-2008-01-132134
- Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 tesla: a comparative study. Invest Radiol 2007;42:449-459 https://doi.org/10.1097/01.rli.0000262089.55618.18
- Khodarahmi I, Fritz J. The value of 3 tesla field strength for musculoskeletal magnetic resonance imaging. Invest Radiol 2021;56:749-763 https://doi.org/10.1097/RLI.0000000000000801
- Willinek WA, Gieseke J, Kukuk GM, Nelles M, Konig R, Morakkabati-Spitz N, et al. Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 2010;256:966-975 https://doi.org/10.1148/radiol.10092127
- Kenkel D, Wurnig MC, Filli L, Ulbrich EJ, Runge VM, Beck T, et al. Whole-body diffusion imaging applying simultaneous multi-slice excitation. Rofo 2016;188:E1
- Taron J, Schraml C, Pfannenberg C, Reimold M, Schwenzer N, Nikolaou K, et al. Simultaneous multislice diffusion-weighted imaging in whole-body positron emission tomography/magnetic resonance imaging for multiparametric examination in oncological patients. Eur Radiol 2018;28:3372-3383 https://doi.org/10.1007/s00330-017-5216-y
- Moore MM, Iyer RS, Sarwani NI, Sze RW. Artificial intelligence development in pediatric body magnetic resonance imaging: best ideas to adapt from adults. Pediatr Radiol 2022;52:367-373 https://doi.org/10.1007/s00247-021-05072-1
- Zormpas-Petridis K, Tunariu N, Curcean A, Messiou C, Curcean S, Collins DJ, et al. Accelerating whole-body diffusion-weighted MRI with deep learning-based denoising image filters. Radiol Artif Intell 2021;3:e200279
- Jung W, Kim EH, Ko J, Jeong G, Choi MH. Convolutional neural network-based reconstruction for acceleration of prostate T2 weighted MR imaging: a retro- and prospective study. Br J Radiol 2022;95:20211378